ArticleFrontiers in immunology2025

Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial.

Jing Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.